Atlas FDA

LINX Reflux Management System

FDA premarket approval P100049/S034 · decided 2022-06-09

Approval details

PMA number
P100049
Supplement
S034
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LINX Reflux Management System
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2022-05-10
Decision date
2022-06-09
Days to decision
30 days
Decision code
OK30
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
Qualification of a new components supplier for the LINX Reflux Management System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.